November 25, 2014 10:43 pm | Updated 10:43 pm IST - HYDERABAD:
Aurobindo Pharma USA on Tuesday announced that it was voluntarily recalling a product lot of its epilepsy drug, Gabapentin capsules, after the lot was found to contain some empty capsules.
Empty capsules could result in missed dose(s) of Gabapentin, which is used in the treatment of epilepsy and for the management of postherpetic neuralgia (pain after shingles), resulting in adverse health consequences, the company said in a release.
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.
